Aarey Drugs & Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 128.49 | 215.49 | 76.77 |
| Operating Expense | 125.73 | 211.79 | 73.77 |
| Net Profit | 1.24 | 2.15 | 1.91 |
| Net Profit Margin | 0.97 | 1.00 | 2.49 |
| Earning Per Share | 0.44 | 0.77 | 0.75 |
| EBIDTA | 2.77 | 4.36 | 3 |
| Effective Tax Rate | 3.64 | 17.84 | -14.67 |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 128.49 |
| Operating Expense | 125.73 |
| Net Profit | 1.24 |
| Net Profit Margin | 0.97 |
| Earning Per Share | 0.44 |
| EBIDTA | 2.77 |
| Effective Tax Rate | 3.64 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 395.62 | 418.96 | 492.76 |
| Operating Expenses Annual | 391.17 | 411.24 | 481.37 |
| Operating Profit Annual | 11.42 | 10.45 | 14.06 |
| Interest Annual | 4.38 | 2.87 | 2.04 |
| Depreciation | 1.70 | 1.57 | 1.99 |
| Net Profit Annual | 4.68 | 3.77 | 6.55 |
| Tax Annual | 0.66 | 2.24 | 3.48 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 395.62 |
| Operating Expenses Annual | 391.17 |
| Operating Profit Annual | 11.42 |
| Interest Annual | 4.38 |
| Depreciation | 1.70 |
| Net Profit Annual | 4.68 |
| Tax Annual | 0.66 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.71 | 0.19 | 0.65 |
| Cash Flow from Operations | -2.99 | -1.28 | 0.50 |
| Cash Flow from Investing | -1.70 | 0.44 | -3.21 |
| Cash Flow from Financing | 5.58 | 1.35 | 2.25 |
| Cash Flow at the End | 1.59 | 0.71 | 0.19 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.71 |
| Cash Flow from Operations | -2.99 |
| Cash Flow from Investing | -1.70 |
| Cash Flow from Financing | 5.58 |
| Cash Flow at the End | 1.59 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 2.89 | 2.49 | 2.86 |
| PBIT Margin (%) | 2.46 | 2.12 | 2.45 |
| PBT Margin (%) | 1.90 | 1.38 | 1.25 |
| Net PROFIT Margin (%) | 1.18 | 0.90 | 1.33 |
| Return On Networth / Equity (%) | 3.74 | 3.26 | 6.16 |
| Return On Networth /Employed (%) | 6.09 | 6.28 | 9.79 |
| Return On Assets (%) | 2.93 | 2.66 | 5.32 |
| Total Debt / Equity (X) | 0.28 | 0.22 | 0.15 |
| Asset Turnover Ratio (%) | 2.48 | 2.96 | 4 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 2.89 |
| PBIT Margin (%) | 2.46 |
| PBT Margin (%) | 1.90 |
| Net PROFIT Margin (%) | 1.18 |
| Return On Networth / Equity (%) | 3.74 |
| Return On Networth /Employed (%) | 6.09 |
| Return On Assets (%) | 2.93 |
| Total Debt / Equity (X) | 0.28 |
| Asset Turnover Ratio (%) | 2.48 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Fixed Assets Annual | 13.94 | 14.47 | 14.26 |
| Total Current Assets Annual | 270.61 | 218.82 | 218.38 |
| Non Current Assets Annual | 20.72 | 26.35 | 14.66 |
| Total Shareholders Funds Annual | 117.41 | 113.64 | 98.86 |
| Total Assets Annual | 291.32 | 245.17 | 233.04 |
| Particulars | Mar 2023 |
|---|---|
| Fixed Assets Annual | 13.94 |
| Total Current Assets Annual | 270.61 |
| Non Current Assets Annual | 20.72 |
| Total Shareholders Funds Annual | 117.41 |
| Total Assets Annual | 291.32 |
No Data Availabe
